| Name |
TSC22D1
|
| Type |
somatic mutation
|
| Species |
Homo sapiens
|
| Tissue |
TGFB (R&D), Tig3(et)-16i and HaCaT cells
|
| Experiment Method |
qPCR
|
| Up/Down |
NA
|
| Pro/Anti |
Pro
|
| Funtion Description |
Gene-expression profiling revealed a >100-fold increase in the levels of the transcription factor and putative tumour suppressor gene TGFB-stimulated clone 22 (TSC22D1) in BRAF(E600)-induced senescence, in both human fibroblasts and melanocytes. Only the
|
| Regulation Gene |
TSC22D1
|
| Year |
2011
|
| Pubmed ID |
21448135
|
| Title |
Antagonistic TSC22D1 variants control BRAF(E600)-induced senescence
|
| Drug |
NA
|
| Disease |
NA
|
| Environment Factors |
NA
|
| Circulating |
NA
|
| Variant |
somatic mutation
|
| High-throughput |
NA
|